Skip to content

LIFE Child (LIFE Leipzig Research Centre for Civilization Diseases)

Prospective Population-based Childhood Cohort Study in the Leipzig Area Investigating Genetic, Environmental, and Metabolic Factors and Their Association With the Development of Civilization Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02550236
Enrollment
7000
Registered
2015-09-15
Start date
2010-10-31
Completion date
2026-12-31
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Development

Keywords

Children, Pregnancy, Growth, Lifestyle, Metabolic and cardiovascular health, Birth, Development, Reference Values

Brief summary

The Leipzig Research Centre for Civilization Diseases (LIFE) Child Study is a prospective longitudinal population-based study with a life course approach to health and disease. The LIFE Child Study focuses on two main research objectives: * What are premises of normal growth, development and health in children? * Which factors contribute to the development of non-communicable diseases such as childhood obesity and its co-morbidities, atopy and mental health problems? Detailed assessments will be conducted alongside long-term storage of biological samples in 1,000 pregnant women and more than 5,000 children and their families.

Detailed description

* The LIFE Child study is part of LIFE, a life sciences research program of the University of Leipzig (Leipzig Research Centre for Civilization Diseases - LIFE). The measurements are performed in a well-equipped research centre located on the premises of the University Hospital of Leipzig. * The study collects detailed information from clinical examinations, questionnaires and interviews and includes a collection of several types of biological materials at various time points (urine, stool, hair, blood for direct analyses, genomic DNA, dried blood spots, paxgenes (for RNA isolation and expression/eQTL studies). Children and adolescents from 0 to 20 years at baseline and their families are included. Participants are followed annually over a period of several years irrespective of the age at the first participation in the study until they reach the age of 20. * Prenatal examinations are conducted in the 24th and 36th week of gestation and postnatal examinations in the 3rd, 6th and 12th month in the offspring. The birth cohort study collects detailed information from clinical examinations, questionnaires and interviews and biological materials (blood, cord blood, placental tissue, breast milk, hair, urine and stool) * In addition, the LIFE Child study focuses in the disease cohort LIFE Child OBESITY and disease free controls in more detail. The aim of these subgroups is to examine aetiological associations and comorbidities with more in-depth methods.

Interventions

None listed

Sponsors

European Social Fund
CollaboratorOTHER
European Regional Development Fund
CollaboratorOTHER
Free State of Saxony
CollaboratorUNKNOWN
Helmholtz Center for Environmental Research Leipzig
CollaboratorUNKNOWN
Leipzig Research Center for Early Child Development
CollaboratorUNKNOWN
Robert Koch Institute Berlin
CollaboratorUNKNOWN
University of Leipzig
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* children with their families and pregnant women of the area of Leipzig

Exclusion criteria

* severe diseases

Design outcomes

Primary

MeasureTime frameDescription
Civilization diseases and their risk factors20 yearsAssess lifestyle, metabolic and genetic risk factors of civilization diseases (e.g. diabetes mellitus, obesity, allergy, cardiovascular diseases) from fetal life to adulthood.

Countries

Germany

Contacts

Primary ContactAntje Körner, Prof., MD
antje.koerner@medizin.uni-leipzig.de
Backup ContactLIFE Child
lifechild@medizin.uni-leipzig.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026